InflaRx (IFRX) Revenue (2023 - 2026)
InflaRx's (IFRX) quarterly Revenue came in at $45834.3 in Q2 2026, up 2.69% year-over-year from $44635.4 in Q2 2025, and up 216.04% quarter-over-quarter from -$39497.2 in Q4 2025.
Analysis
InflaRx (IFRX) Revenue (2023 - 2026) Analysis & Trends
InflaRx has disclosed Revenue across 4 years of filings, most recently posting $45834.3 for Q2 2026.
- In Q2 2026, Revenue rose 2.69% year-over-year to $45834.3; the TTM figure through Jun 2026 stood at $78831.1 (down 63.85% YoY), while the FY2025 annual figure was $33138.5, down 81.29% from the prior year.
- Revenue came in at $45834.3 for Q2 2026 at InflaRx, up from -$39497.2 in the prior quarter.
- In the past five years, Revenue ranged from a high of $135980.4 in Q3 2024 to a low of -$39497.2 in Q4 2025.
- Average Revenue over 4 years is $33355.5, with a median of $37906.8 recorded in 2025.
- The largest YoY upside for Revenue was 552.01% in 2025 against a maximum downside of 8638.0% in 2025.
- Over 4 years, Revenue stood at $2459.6 in 2023, then sank by 118.38% to -$452.02 in 2024, then slumped by 8638.0% to -$39497.2 in 2025, then jumped by 216.04% to $45834.3 in 2026.
- Per Business Quant data, the three most recent Revenue figures were $45834.3 in Q2 2026, -$39497.2 in Q4 2025, and $27858.6 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.44 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | 45,834.25 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45,834.25 |
| Dec 31, 2025 | -39,497.16 |
| Sep 30, 2025 | 27,858.58 |
| Jun 30, 2025 | 44,635.43 |
| Mar 31, 2025 | 37,906.76 |
| Dec 31, 2024 | -452.02 |
| Sep 30, 2024 | 135,980.44 |
| Jun 30, 2024 | 6,845.77 |
| Mar 31, 2024 | 39,149.22 |
| Dec 31, 2023 | 2,459.60 |
| Sep 30, 2023 | 66,189.57 |